» Articles » PMID: 18568157

The Human Oxygen Sensing Machinery and Its Manipulation

Overview
Journal Chem Soc Rev
Specialty Chemistry
Date 2008 Jun 24
PMID 18568157
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Animals respond to the challenge of limited oxygen availability by a coordinated response that works to increase oxygen supply and minimize tissue damage. The chronic hypoxic response is mediated by the alpha,beta-hypoxia inducible transcription factor (HIF) that enables the expression of a gene array. Because this array includes genes encoding for proteins that regulate processes including red blood cell and blood vessel formation, manipulation of the HIF system has potential for the treatment of ischemic diseases, anaemia and tumours. Hydroxylase enzymes act as oxygen sensors by regulating both the lifetime of HIF-alpha and its transcriptional activity. This tutorial review aims to provide a non-expert introduction to the HIF field by providing a background to current work, summarising molecular knowledge on the HIF system, and outlining opportunities for therapeutic intervention.

Citing Articles

Role of Sodium-Dependent Vitamin C Transporter-2 and Ascorbate in Regulating the Hypoxic Pathway in Cultured Glioblastoma Cells.

Burgess E, Praditi C, Phillips E, Vissers M, Robinson B, Dachs G J Cell Biochem. 2024; 126(1):e30658.

PMID: 39382087 PMC: 11729540. DOI: 10.1002/jcb.30658.


Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.

Figg Jr W, Fiorini G, Chowdhury R, Nakashima Y, Tumber A, McDonough M Proteins. 2023; 91(11):1510-1524.

PMID: 37449559 PMC: 10952196. DOI: 10.1002/prot.26541.


Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease.

Lun J, Zhang H, Guo J, Yu M, Fang J Front Pharmacol. 2023; 14:1045997.

PMID: 37201028 PMC: 10187758. DOI: 10.3389/fphar.2023.1045997.


Activation of immune signals during organ transplantation.

Li Q, Lan P Signal Transduct Target Ther. 2023; 8(1):110.

PMID: 36906586 PMC: 10008588. DOI: 10.1038/s41392-023-01377-9.


Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib.

Jiang Z, Dai C J Hepatocell Carcinoma. 2023; 10:257-266.

PMID: 36815094 PMC: 9939808. DOI: 10.2147/JHC.S396231.